Pfizer's $2.3B Trillium Deal Closes Without FTC Challenge
By Nadia Dreid ( November 17, 2021, 6:43 PM EST) -- Pfizer finished up its $2.3 billion takeover of blood cancer drugmaker Trillium Therapeutics on Wednesday after the Federal Trade Commission's time to raise antitrust concerns pre-merger ran out....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.